Inhibition of FGF‐FGFR and VEGF‐VEGFR signalling in cancer treatment

The sites of targeted therapy are limited and need to be expanded. The FGF‐FGFR signalling plays pivotal roles in the oncogenic process, and FGF/FGFR inhibitors are a promising method to treat FGFR‐altered tumours. The VEGF‐VEGFR signalling is the most crucial pathway to induce angiogenesis, and inh...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Guihong, Chen, Tao, Ding, Zhenyu, Wang, Yang, Wei, Yuquan, Wei, Xiawei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016646/
https://www.ncbi.nlm.nih.gov/pubmed/33655556
http://dx.doi.org/10.1111/cpr.13009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016646/
https://www.ncbi.nlm.nih.gov/pubmed/33655556
http://dx.doi.org/10.1111/cpr.13009

Ejemplares similares